Tumor suppressor P53: Regulation and function

被引:120
作者
Somasundaram, K
El-Deiry, WS
机构
[1] Univ Penn, Sch Med, Lab Mol Oncol & Cell Cycle Regulat, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Howard Hughes Med Inst, Dept Med, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Howard Hughes Med Inst, Dept Genet, Philadelphia, PA 19104 USA
[4] Univ Penn, Sch Med, Ctr Canc, Philadelphia, PA 19104 USA
关键词
p53; apoptosis; cell cycle; cancer; tumor suppressor; p73; review;
D O I
10.2741/Somasund
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The p53 protein is a transcription factor involved in maintaining genomic integrity by controlling cell cycle progression and cell survival. Mutations in p53 are the most frequently seen genetic alterations in human cancer. The function of p53 is critical to the way many cancer treatments kill cells because radiotherapy and chemotherapy act in part by triggering programmed cell death in response to DNA damage. Consequently, tumors which bear p53 mutations, are often difficult to treat and their prognosis is poor. Since the underlying feature of tumors with p53 mutations is the absence of functional p53, gene replacement therapy with wild-type p53 gene is being considered as an approach for treating a variety of cancers. In recent years, more information has been obtained regarding various pathways leading to the activation of p53, particularly those involving post-translational modifications of p53. Several new target genes of p53 have been identified. This review will summarize current knowledge on the structure, mechanism of activation and effectors of p53 function.
引用
收藏
页码:D424 / D437
页数:14
相关论文
共 155 条
[91]   P53 IS PHOSPHORYLATED IN-VITRO AND IN-VIVO BY AN ULTRAVIOLET RADIATION-INDUCED PROTEIN-KINASE CHARACTERISTIC OF THE C-JUN KINASE, JNK1 [J].
MILNE, DM ;
CAMPBELL, LE ;
CAMPBELL, DG ;
MEEK, DW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (10) :5511-5518
[92]  
MILNE DM, 1994, J BIOL CHEM, V269, P9253
[93]  
MIYASHITA T, 1995, CELL, V80, P293
[94]  
MIYASHITA T, 1994, CANCER RES, V54, P3131
[95]  
MOSNER JT, 1995, EMBO J, V15, P4442
[96]   Effects of p21Cip1/Waf1 at both the G1/S and the G2/M cell cycle transitions:: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication [J].
Niculescu, AB ;
Chen, XB ;
Smeets, M ;
Hengst, L ;
Prives, C ;
Reed, SI .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (01) :629-643
[97]  
Nielsen LL, 1997, CANCER GENE THER, V4, P129
[98]   A novel brain-specific p53-target gene, BAI1, containing thrombospondin type 1 repeats inhibits experimental angiogenesis [J].
Nishimori, H ;
Shiratsuchi, T ;
Urano, T ;
Kimura, Y ;
Kiyono, K ;
Tatsumi, K ;
Yoshida, S ;
Ono, M ;
Kuwano, M ;
Nakamura, Y ;
Tokino, T .
ONCOGENE, 1997, 15 (18) :2145-2150
[99]   CLONING OF SENESCENT CELL-DERIVED INHIBITORS OF DNA-SYNTHESIS USING AN EXPRESSION SCREEN [J].
NODA, A ;
NING, Y ;
VENABLE, SF ;
PEREIRASMITH, OM ;
SMITH, JR .
EXPERIMENTAL CELL RESEARCH, 1994, 211 (01) :90-98
[100]  
OConnor PM, 1997, CANCER SURV, V29, P151